In the BioHarmony Drug Report Database
Nepafenac
Ilevro, Nevanac (nepafenac) is a small molecule pharmaceutical. Nepafenac was first approved as Ilevro on 2005-08-19. It is used to treat eye pain in the USA. It has been approved in Europe to treat ophthalmologic surgical procedures and postoperative pain. Nevanac’s patents are valid until 2032-03-31 (FDA).
Trade Name
|
Nevanac |
|---|---|
Common Name
|
nepafenac |
ChEMBL ID
|
CHEMBL1021 |
Indication
|
eye pain, ophthalmologic surgical procedures, postoperative pain |
Drug Class
|
Anti-inflammatory agents (acetic acid derivatives) |
Image (chem structure or protein)